Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 07, 2025 02:00 ET | Source: Memo Therapeutics AG

Memo Therapeutics AG Presents Long Term Follow-Up Data from its Phase II SAFE KIDNEY Trial of Potravitug and Real World Data on the Challenges and Re-source Utilization of Managing Kidney Transplant Recipients at ASN Kidney Week Meeting

PRESS RELEASE Memo Therapeutics AG Presents Long Term Follow-Up Data from its Phase II SAFE KIDNEY Trial of Potravitug and Real World Data on the Challenges and Resource Utilization of Managing...
November 06, 2025 09:51 ET | Source: Vera Therapeutics

Vera Therapeutics Announces Positive ORIGIN Phase 3 Data for Atacicept in IgA Nephropathy Presented at ASN Kidney Week 2025 and Published in the New England Journal of Medicine

Atacicept met the primary endpoint of reduction in proteinuria (UPCR) at week 36; participants receiving atacicept achieved a 46% reduction from baseline and 42% reduction compared to placebo at week...
November 05, 2025 07:29 ET | Source: Vera Therapeutics

Vera Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results

Vera Therapeutics today reported its business highlights and financial results for the third quarter ended September 30, 2025
June 27, 2024 02:00 ET | Source: Nokia Oyj

Nokia sopimukseen Ranskan valtion kanssa johtavan, merenalaisten verkkojen ASN-liiketoiminnan myynnistä

Lehdistötiedote Nokia sopimukseen Ranskan valtion kanssa johtavan, merenalaisten verkkojen ASN-liiketoiminnan myynnistä Nokia ja Ranskan valtio ovat allekirjoittaneet myyntioption ASN:stä 350...
June 27, 2024 02:00 ET | Source: Nokia Oyj

Nokia enters into an agreement with the French State regarding the sale of leading submarine networks business ASN

Press ReleaseNokia enters into an agreement with the French State regarding the sale of leading submarine networks business ASN Nokia has signed a put option agreement with the French State...
May 28, 2024 10:28 ET | Source: AmeriCorps

AmeriCorps Introduces Transformative Rule to Boost Grant Flexibility and Empower National Service Programs

Washington, DC, May 28, 2024 (GLOBE NEWSWIRE) -- AmeriCorps, the federal agency for national service and volunteerism, announced a final rule for the AmeriCorps State and National program. This...
October 13, 2023 16:30 ET | Source: Travere Therapeutics, Inc.

Travere Therapeutics to Present Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023

Two late-breaking high-impact oral presentations of the Phase 3 PROTECT Study of FILSPARI® (sparsentan) in IgAN and Phase 3 DUPLEX Study of sparsentan in FSGS 11 total abstracts accepted for...
November 03, 2022 09:00 ET | Source: SeaStar Medical Holding Corporation

SeaStar Medical (Nasdaq: ICU) Announces Positive Interim Safety Findings from Ongoing Study Evaluating the Selective Cytopheretic Device (SCD) in Children

Data being presented at the American Society of Nephrology (ASN) Kidney Week 2022 Interim study data show that SCD treatment is safe to use in pediatric patients with Acute Kidney Injury (AKI)...
October 26, 2022 16:30 ET | Source: Travere Therapeutics, Inc.

Travere Therapeutics Announces Presentations and Posters at American Society of Nephrology Kidney Week 2022

SAN DIEGO, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the Company and its collaborators will present data from its sparsentan programs,...
October 25, 2021 07:00 ET | Source: FibroGen, Inc.

FibroGen Announces Analyses from Roxadustat Global Phase 3 Program at American Society of Nephrology Kidney Week 2021

SAN FRANCISCO, Oct. 25, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), today announced that analyses from the global Phase 3 roxadustat clinical program will be presented at the American...